HealthQuill Pharma
Women stand to benefit more than men when they indulge in physical activities as it lowers the risk of premature death or fatal cardiovascular events, according to a study conducted by the US-based National Institutes of Health.
Drugs Health Pharma

FDA warning on Veozah: Liver injury risk linked to menopausal drug

HQ Team September 13, 2024: The U.S. Food and Drug Administration (FDA) has issued a safety warning about Veozah (fezolinetant), a medication prescribed.

Read More
Eli Lilly and Company will invest one billion dollars to expand its facility in Ireland to increase its production of drugs to treat Alzheimer’s disease, diabetes and obesity, according to a company statement.
Drugs Health Pharma

Eli Lilly to invest $1b in Irish facility to make Alzheimer’s, obesity drugs

Eli Lilly and Company will invest one billion dollars to expand its facility in Ireland to increase its production of drugs to treat.

Read More
A global goal to reduce methane emissions “ seems as distant as a desert oasis” now, as about two-thirds of it comes from human activities such as fossil fuels, agriculture and landfills, researchers find.
Climate Health Pharma

Global goal to cut methane emissions as distant as a ‘desert oasis’

A global goal to reduce methane emissions “ seems as distant as a desert oasis” now, as about two-thirds of it comes from.

Read More
Dementia, Behavioural Disorders, ADHD
Drugs Health Opinion Pharma

Opinion: Proxy parenting not ideal, leads to depression, anxiety in children 

The phrase "It takes a village to raise a child" emphasizes the importance of children interacting with diverse individuals beyond their immediate family..

Read More
https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_ppi.pdf
Drugs Health Pharma

Merck meets main goal during end-stage trial of HPV vaccine in Japan

Merck & Co., announced it has met its primary and secondary goals during the end-stage trials of its human papillomavirus (HPV) vaccine in.

Read More
Exposure to certain endocrine-disrupting chemicals, especially musk ambrette, may trigger early puberty in girls, a study by the National Institutes of Health finds.
Drugs Health Pharma

Endocrine-disrupting chemicals may trigger early puberty in girls

Exposure to certain endocrine-disrupting chemicals, especially musk ambrette, may trigger early puberty in girls, a study by the National Institutes of Health finds.

Read More
People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing Parkinson’s disease, a Beth Israel Deaconess Medical Center study finds.
Drugs Health Pharma

GI tract damage may increase the risk of Parkinson’s disease by 76% 

People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing.

Read More
Sudan’s civil war is a “nightmare” and the World Health Organization has called on the international community to broker peace and provide the necessary short and long-term aid for the largest internal displacement of people in the world today.
Drugs Health Pharma

Sudan’s civil war is a ‘nightmare,’ WHO calls for urgent global action, aid

Sudan’s civil war is a “nightmare” and the World Health Organization has called on the international community to broker peace and provide the.

Read More
EQT Private Capital Asia will acquire a controlling stake in GeBBS Healthcare Solutions, a provider of healthcare outsourcing solutions from ChrysCapital, according to a statement from EQT.
Drugs Health Pharma

EQT Private Capital Asia to acquire controlling stake in US-based GeBBS

EQT Private Capital Asia will acquire a controlling stake in GeBBS Healthcare Solutions, a provider of healthcare outsourcing solutions from ChrysCapital, according to.

Read More
Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%, the latest results of the company's trials reveal.
Drugs Health Pharma

Summit’s lung cancer drug reduces risk of disease progression by 48%

Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%,.

Read More